Sprig is pediatric dentistry’s leading technology and clinical education company. Since creating the first pediatric Zirconia crown, Sprig has continued to develop new and better solutions, from patented crown design that maximizes mechanical retention to a custom bur system that optimizes seating. Sprig leads the way in professional education through Sprig University, a celebrated continuing education program that teaches proprietary prep and seating techniques to help reduce chair time, alleviate clinical frustrations and grow dental practices. Sprig is constantly pushing the boundaries of pediatric dental innovation to ensure the next generation has next generation care.
Dr. John Hansen and Dr. Jeffrey Fisher make the decision to found EZPEDO, Inc. and develop the world’s first pediatric Zirconia crown.
First prototypes of pediatric Zirconia crowns are engineered and produced in Dr. Hansen’s cosmetic dental laboratory.
An EZPEDO Zirconia crown is seated on a pediatric patient for the first time.
Zir-Lock retention feature with internal mechanical grooves is developed to dramatically improve clinical longevity.
Space-Loss sized first molars are developed, the ezpedo.com website is launched, and Zirconia crowns are first offered for sale to pediatric dentists.
EZ-Seat contour modifications are made to the occlusal profile and relaxed undercuts are introduced.
Zir-Plus hybrid surface treatment developed with a synergistic use of glaze and polish for a nearly flawless combination of visual aesthetics and occlusal function.
Zir-Lock Ultra is introduced with the added benefits of Margin Lock. A design patent is granted for the Zir-Lock retention feature. EZPEDO University—dentistry’s premier, hands-on, over-the-shoulder instructional program in the use of pediatric Zirconia crowns—is launched.
Second generation Posterior V2 crowns with Flat-Fit modified contours are introduced. Which require less tooth prep.
EZPEDO Magazine launches. A bi-annual magazine featuring relevant cases and studies.
Siegelvision, an organizational identity consultancy in New York, is hired to initiate the process of repositioning EZPEDO as a next-generation, oral health technology company.
EZPEDO rebrands to Sprig Oral Health Technologies, Inc. EZPEDO patents key crown features. Sprig introduces HemeRx, the first hemostatic agent for pediatrics, and SmartMTA, the first fast-set MTA for bioregenerative pulp therapy.
Sprig Oral Health Technologies, Inc receives it’s MDSAP and European CE certificates, which opens up direct shipment to international customers.
